Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase 2 Study of PLX3397 in Patients With Recurrent Glioblastoma

This study has been completed.
Information provided by (Responsible Party):
Plexxikon Identifier:
First received: May 4, 2011
Last updated: April 6, 2015
Last verified: April 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2015
  Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 6, 2015